openPR Logo
Press release

Global Erythropoietin (EPO) Market 2016 - Amgen, Johnson & Johnson, Roche, Kyowa Hakko Kirin, 3SBIO

01-09-2017 03:02 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fior Markets

Global Erythropoietin (EPO) Market 2016 - Amgen, Johnson &

Erythropoietin, also known as EPO, hematopoietin, or hemopoietin, is a glycoprotein hormone that controls erythropoiesis, or red blood cell production. It is a cytokine (protein signaling molecule) for erythrocyte (red blood cell) precursors in the bone marrow. Human EPO has a molecular weight of 34 kDa.

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.

Download sample report at http://www.fiormarkets.com/report-detail/19781/request-sample

Exogenous erythropoietin can be provided to people whose kidneys cannot make enough. Recombinant human erythropoietin (rhEPO) is produced by recombinant DNA technology in cell culture. Several different pharmaceutical agents are available with a variety of glycosylation patterns and are collectively called erythropoiesis-stimulating agents (ESA). Major examples are epoetin alfa and epoetin beta. The specific details for labeled use vary between the package inserts, but ESAs have been used in the treatment of anemia in chronic kidney disease, anemia in myelodysplasia, and in anemia from cancer chemotherapy. Boxed warnings include a risk of death, myocardial infarction, stroke, venous thromboembolism, and tumor recurrence. rhEPO has been used illicitly as a performance-enhancing drug; it can often be detected in blood, due to slight differences from the endogenous protein, for example, in features of posttranslational modification.

This report provides detailed analysis of worldwide markets for Erythropoietin (EPO) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Erythropoietin (EPO) market and further lays out an analysis of the factors influencing the supply/demand for Erythropoietin (EPO), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

Access full report at http://www.fiormarkets.com/report/global-erythropoietin-epo-market-outlook-2016-2021-19781.html

Global Erythropoietin (EPO) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Erythropoietin (EPO) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Erythropoietin (EPO) market are Amgen (USA), Johnson & Johnson (USA), Roche (Switzerland), Kyowa Hakko Kirin (Japan), 3SBIO (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Erythropoietin (EPO) industry has been provided.

Fior Markets is a leading market intelligence company that sells reports of top publishers in the technology industry.

Our extensive research reports cover detailed market assessments that include major technological improvements in the industry. Fior Markets also specializes in analyzing hi-tech systems and current processing systems in its expertise.

Contact Us
Mark Stone
Sales Manager
Phone: (201) 465-4211
Email: sales@fiormarkets.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Erythropoietin (EPO) Market 2016 - Amgen, Johnson & Johnson, Roche, Kyowa Hakko Kirin, 3SBIO here

News-ID: 408561 • Views: 583

More Releases from Fior Markets

Global Animal Parasiticides Market is Expected to Grow to USD 14.49 Billion at a …
Animal Parasiticides Market by Animal Type (Food-producing Animals, Companion Animals), Product Type (Endoparasiticides, Ectoparasiticides, Endectocides), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2020 to 2027 is the detailed research added by Fior Markets which mainly focuses on the aspects that tend to offer a complete overview and analysis of the market. The report offers a comprehensive analysis of the developments, growth outlook, driving factors, and key
Global Almond Ingredients Market is Expected to Grow to USD 20.3 Billion at a CA …
Almond Ingredients Market By Application (Bakery & Confectionery, Milk Substitutes & Ice Cream, Snacks & Bars, Nut & Seed Butters, Cosmetics, RTE Cereals), By Type (Pieces, Flour, Whole, Milk, Paste, Extracts, Oil), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2020 to 2027 is the detailed research added by Fior Markets which mainly focuses on the aspects that tend to offer a complete overview and analysis of
Air circuit Breaker Market is Expected to Grow to USD 4.5 Billion at a CAGR of 5 …
Air Circuit Breaker Market by Type (Plain Air Circuit Breaker and Air Blast Circuit Breaker), Application (Commercial, Residential, and Industrial), Voltage (Low Voltage and Medium Voltage), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2020 to 2027 is the detailed research added by Fior Markets which mainly focuses on the aspects that tend to offer a complete overview and analysis of the market. The report offers a
Aerosol Valves Market is Expected to Grow to USD 4.03 Billion at a CAGR of 4.03% …
Aerosol Valves Market By Type (Continuous, Metered), Application (Homecare, Personal Care, Automotive, Food, Paints, Healthcare), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2020 to 2027 is the detailed research added by Fior Markets which mainly focuses on the aspects that tend to offer a complete overview and analysis of the market. The report offers a comprehensive analysis of the developments, growth outlook, driving factors, and key

All 5 Releases


More Releases for EPO

EPO biomarkers Market Trends 2018 | Segmentation, Outlook, Industry Report to 20 …
Erythropoietin (EPO) is a hormone that is produced from the kidney inside the human body. EPO biomarkers Market are used to increase the growth of red blood cells in the body by stimulating the bone marrow. Some of the EPO biomarkers available in the market are epoetin alfa, epoetin beta, epoetin zeta, epoetin theta, recombinant human erythropoietin, and darbepoetin alfa. Erythropoietin alfa is used to treat anemia and cancer
Global EPO Biomarkers Market Research and Forecast 2018-2023
Global EPO biomarkers market size, market intelligence, market trends, research and analysis report by biomarker (erythropoietin alfa, beta, zeta, theta, recombinant human erythropoietin, darbepoetin alfa) by applications (end-stage renal disorder, cancers, rheumatoid arthritis, aids, myelodysplastic syndrome, neurology, hematology) forecast 2018-2023 According to the OMR analysis, the global EPO biomarkers Market is expected to grow impressively during 2018-2023. The global EPO biomarkers market is segmented on the basis of biomarker type, applications,
Quercetin Market Global Forecast 2018 | Studied By Monteloeder, EPO S.r.l., King …
UpMarketResearch published an exclusive report on “Quercetin market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 112 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. This report focuses on the Quercetin market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa.
Global Erythropoietin (EPO) Market 2017 - Johnson & Johnson, Roche, Kyowa Hakko …
Global Erythropoietin (EPO) market Report offers decisive insights into the overall Erythropoietin (EPO) industry along with the market dimensions and evaluation for the duration 2017 to 2022. The forenamed research study covers extensive analysis of various Erythropoietin (EPO) industry segments based on the type of applications, type of product Components and services, and different geographical regions. Erythropoietin, also known as EPO, hematopoietin, or hemopoietin, is a glycoprotein hormone that controls
EPO Biosimilars - The Future of Erythropoietin Market
ReportsWorldwide has announced the addition of a new report title EPO Biosimilars - The Future of Erythropoietin Market to its growing collection of premium market research reports. Erythropoietin is a hormone produced by healthy kidneys. This hormone prompts the bone marrow to make the red blood cells, which then carry oxygen throughout the body. Erythropoietin is used to treat anemia resulting from kidney failure or cancer treatment. It is considered to
Global Erythropoietin (EPO) Market with Focus on Asia: Industry Analysis & Outlo …
Erythropoietin is a substance produced by the kidney that leads to the formation of red blood cells in the bone marrow. It is a glycoprotein hormone which regulates erythropoiesis (Red Blood Cell production). For erythrocyte precursors present in the bone marrow, EPO acts as a cytokine. Commonly referred to as hematopoietin or hemopoietin, erythropoietin is also known to have other biological functions, such as involvement in the wound healing cycle